Monitoring tumor response to neoadjuvant chemotherapy using MRI and (18)F-FDG PET/CT in breast cancer subtypes

PURPOSE: To explore guidelines on the use of MRI and PET/CT monitoring primary tumor response to neoadjuvant chemotherapy (NAC), taking breast cancer subtype into account. MATERIALS AND METHODS: In this prospective cohort study, 188 women were included with stages II and III breast cancer. MRI and (...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitz, Alexander M. Th., Teixeira, Suzana C., Pengel, Kenneth E., Loo, Claudette E., Vogel, Wouter V., Wesseling, Jelle, Rutgers, Emiel J. Th., Valdés Olmos, Renato A., Sonke, Gabe S., Rodenhuis, Sjoerd, Vrancken Peeters, Marie Jeanne T. F. D., Gilhuijs, Kenneth G. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439668/
https://www.ncbi.nlm.nih.gov/pubmed/28531188
http://dx.doi.org/10.1371/journal.pone.0176782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439668/
https://www.ncbi.nlm.nih.gov/pubmed/28531188
http://dx.doi.org/10.1371/journal.pone.0176782

Ejemplares similares